Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Dana Farber Cancer Inst
Boston, Massachusetts
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 136
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Donald Kufe | Conflict of Interest | Genus Oncology | 2018 | |
| Donald Kufe | Conflict of Interest | Genus Oncology | 2018 | |
| Donald Kufe | Conflict of Interest | Genus Oncology | 2017 | |
| Fritz Roth | Conflict of Interest | Ranomics, Inc. | 2017 | |
| Fritz Roth | Conflict of Interest | Ranomics, Inc. | 2017 | |
| Fritz Roth | Conflict of Interest | SeqWell, Inc. | 2017 | |
| Fritz Roth | Conflict of Interest | SeqWell, Inc. | 2017 | |
| Kenneth Anderson | Conflict of Interest | Acetylon Pharmaceuticals | 2015 | |
| Fritz Roth | Conflict of Interest | SeqWell, Inc. | 2017 | |
| Catherine Wu | Conflict of Interest | Neon Therapuetics | 2017 | |
| Jae Keith Joung | Conflict of Interest | Beam Therapeutics | 2017 | |
| Jae Keith Joung | Conflict of Interest | Beam Therapeutics | 2017 | |
| Jae Keith Joung | Conflict of Interest | Hera Testing Laboratories | 2017 | |
| Jae Keith Joung | Conflict of Interest | Poseida Therapeutics | 2017 | |
| Christopher Sweeney | Conflict of Interest | Leuchemix | 2014 | |
| J. Keith Joung | Conflict of Interest | EpiLogic Therapeutics | 2019 | |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics, Inc. | 2017 | |
| Catherine Wu | Conflict of Interest | Neon Therapeutics | 2017 | |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics | 2018 | |
| Scott Armstrong | Conflict of Interest | C4 Therapeutics | 2018 | |
| Donald Kufe | Conflict of Interest | Genus Oncology | 2018 | |
| Nathanael Gray | Conflict of Interest | C4 Therapuetics | 2017 | |
| Xiaole Shirley Liu | Conflict of Interest | GV20 Oncotherapy | 2019 | |
| Nathanael Gray | Conflict of Interest | Petra Pharmaceuticals | 2018 | |
| J. Keith Joung | Conflict of Interest | Endcadia | 2018 | |
| J. Keith Joung | Conflict of Interest | Blink Therapeutics | 2018 | |
| Donald Kufe | Conflict of Interest | Genus Oncology | 2018 | |
| Donald Kufe | Conflict of Interest | Genus Oncology | 2018 | |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics | 2019 | |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics | 2019 | |
| Nathanael Gray | Conflict of Interest | C4 Therapeutics | 2018 | |
| Xiaole Shirley Liu | Conflict of Interest | GV20 Oncotherapy | 2019 | |
| Umar Mahmood | Conflict of Interest | CytoSite BioPharma, Inc. | 2017 | |
| J Joung | Conflict of Interest | Editas Medicine | 2014 | |
| David Weinstock | Conflict of Interest | Travera, LLC | 2017 | |
| Gordon Harris | Conflict of Interest | Precision Imaging Metrics LLC | 2017 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.